12 results on '"Peter Feng"'
Search Results
2. MM-404 Real-World Belantamab Mafodotin Use: A US Retrospective Longitudinal Pharmacy and Medical Open-Source Claims Database Assessment
3. Treatment Patterns and Patient Outcomes in Relapsed/Refractory Multiple Myeloma (RRMM) Stratified By Exposure to Lenalidomide or Anti-CD38 Therapy and Double-Class Refractory Status: A Retrospective Electronic Health Record Database Study
4. Real-World Outcomes of Medicare Fee-for-Service Beneficiaries Meeting the Eligibility Criteria for the DREAMM-7 and DREAMM-8 Clinical Trials
5. Efficacy and Safety of Third-Line or Later (3L+) Treatments, Including the CD38 Monoclonal Antibody Class, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): A Systematic Literature Review
6. Standards of Care and Treatment Patterns Among Relapsed/Refractory Multiple Myeloma Patients Initiating Second- and Third-Line Therapies
7. P-234: Real-world belantamab mafodotin (belamaf) use: a US retrospective longitudinal pharmacy and medical open-source claims database assessment
8. MM-123: Real-World Study of Treatment Patterns in Heavily Pretreated Relapsed/Refractory Multiple Myeloma (RRMM) in the US
9. Poster: MM-123: Real-World Study of Treatment Patterns in Heavily Pretreated Relapsed/Refractory Multiple Myeloma (RRMM) in the US
10. Poster: MM-451 Treatment Patterns Among Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Receiving Second- and Third-Line Therapy in a Medicare Population
11. Poster: MM-404 Real-World Belantamab Mafodotin Use: A US Retrospective Longitudinal Pharmacy and Medical Open-Source Claims Database Assessment
12. National Trends in the Prevalence of Thrombocytopenia Among Individuals Infected With Hepatitis C Virus, 1999 – 2008
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.